Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany

The recently published S2k-guideline on (allergen-) specific immunotherapy (AIT) provides an excellent overview of the evidence on allergen preparations available for AIT in Germany based on the published efficacy studies. Publications based on the guideline are currently being used by the German as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Allergo J Int
Autores principales: Brehler, Randolf, Klimek, Ludger, Vogelberg, Christian, Werfel, Thomas, Pfaar, Oliver, Hamelmann, Eckard
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Medizin 2016
Materias:
Position Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861740/
https://ncbi.nlm.nih.gov/pubmed/27226950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40629-016-0096-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares